-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades Verona Pharma to Hold, Lowers Price Target to $107

Benzinga·07/09/2025 19:58:00
Listen to the news
Jefferies analyst Suji Jeong downgrades Verona Pharma (NASDAQ:VRNA) from Buy to Hold and lowers the price target from $140 to $107.